TokenPost·
Gilead Agrees to Acquire PepStar’s Oral IL-23R Program for $1.275B
$1.275B
acquisition value
Lead candidate HCXT-2001 is in Phase 1. Closing is expected in the fourth quarter of 2026, subject to customary conditions.
More news
- TokenPostPizza Pizza Royalty Sets October Dividend at $0.0675 Per Share
- TokenPostExtended Completes Arc Migration With $120 Million in TVL Moved
- TokenPostLeonidas Calls on OpenSea to Add Bitcoin (BTC) Ordinals and Runes
- TokenPostMelar Shareholders Approve Everli Deal, Advancing Nasdaq Listing
- CryptopolitanEl-Sayed wants buybacks banned as crypto spends record sums on them
- TokenPostBar Harbor Bankshares Holds Quarterly Dividend at $0.34 Per Share